The latest Cellectar Biosciences Inc (CLRB) Stock Technical Bulletin
Oppenheimer raised the price target for the Cellectar Biosciences Inc (NASDAQ:CLRB) stock to “an Outperform”. The rating was released on July 01, 2020, according to finviz. The stock was initiated by Ladenburg Thalmann, who disclosed in a research note on December 21, 2016, to Buy and set the price objective to $2.70. The latest trade, […]
A Tale from the Dusty Corner: Advantage Solutions Inc. (ADV) Stock
Canaccord Genuity raised the price target for the Advantage Solutions Inc. (NASDAQ:ADV) stock to “a Buy”. The rating was released on December 06, 2023, according to finviz. The research report from Deutsche Bank has initiated the stock to Hold, with a price target set at $7. The stock was downgraded by Goldman, who disclosed in […]
Are PTC Therapeutics Inc’s (PTCT) stock prices rising too high?
Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]
How Vanda Pharmaceuticals Inc (VNDA) Stock converts water flow into cash flow
Jefferies lowered the price target for the Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock from “a Buy” to “a Hold”. The rating was released on February 25, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $14. The stock was upgraded by Citigroup, […]
Yummy or too sour? ThredUp Inc (TDUP) Stock
Telsey Advisory Group lowered the price target for the ThredUp Inc (NASDAQ:TDUP) stock to “an Outperform”. The rating was released on May 07, 2024, according to finviz. We previously noted in another research note published on July 22, 2022 by Piper Sandler that downgraded the stock from an Overweight to a Neutral with a price […]
10x Genomics Inc (TXG) Stock is the one stock you should own forever
TD Cowen lowered the price target for the 10x Genomics Inc (NASDAQ:TXG) stock from “a Buy” to “a Hold”. The rating was released on May 01, 2024, according to finviz. The research report from Wolfe Research has initiated the stock to Outperform, with a price target set at $55. The stock was upgraded by BofA […]
Gaotu Techedu Inc ADR (GOTU) Stock at a key inflection point
CLSA raised the price target for the Gaotu Techedu Inc ADR (NYSE:GOTU) stock from “an Underperform” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 5.30% within the last five trades and 12.73% […]
Is PowerFleet Inc (PWFL) Stock Paving the Way for Earnings?
William Blair raised the price target for the PowerFleet Inc (NASDAQ:PWFL) stock to “an Outperform”. The rating was released on April 03, 2024, according to finviz. The research report from Northland Capital has initiated the stock to Outperform, with a price target set at $7. The stock was initiated by Craig Hallum, who disclosed in […]
Viking Therapeutics Inc (VKTX) Stock to return to profitability in the near future
Oppenheimer raised the price target for the Viking Therapeutics Inc (NASDAQ:VKTX) stock to “an Outperform”. The rating was released on March 26, 2024, according to finviz. The research report from Oppenheimer has reiterated the stock to Outperform, with a price target set at $116. The stock was resumed by ROTH MKM, who disclosed in a […]
Telephone And Data Systems, Inc. (TDS) Stock creates opportunities due to its volume and complexity
JP Morgan raised the price target for the Telephone And Data Systems, Inc. (NYSE:TDS) stock from “a Neutral” to “an Overweight”. The rating was released on August 08, 2023, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $8. The stock was […]
